Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Protocol ID
TOTAL 17
Disease (Sub Disease)
Leukaemia
Lymphoma
Lymphoma
Diagnosis Stage
Newly diagnosed
Location
VIC
Sponsor
St. Jude Children's Research Hospital
Collaborators
Incyte Corporation
Amgen
Servier
Amgen
Servier
Links
Trial Status
Open
Sites
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 2/3
Age Eligibility
1 Year to 18 Years
International registry ID's
NCT03117751
| Study Title | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma |
|---|---|
| Protocol ID | TOTAL 17 |
| Disease (Sub Disease) | Leukaemia Lymphoma |
| Diagnosis Stage | Newly diagnosed |
| Location | VIC |
| Sponsor | St. Jude Children's Research Hospital |
| Collaborators | Incyte Corporation/ Amgen/ Servier |
| Links | https://clinicaltrials.gov/ct2/show/NCT03117751 |
| Trial Status | Open |
| Trial Open Date | 01/12/2021 |
| Sites | Royal Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 2/3 |
| Age Eligibility | 1 Year to 18 Years |
| International registry ID's | NCT03117751 |